title: Quantitative evaluation of retroviral gene transduction efficiency in human lung cancer cells.
abstract: Gene therapy may serve as a valuable therapeutic modality for malignancies, such as lung cancer, that are poorly responsive to conventional therapies. Although many methods for transducing new genes into cells have been described, little is known about gene transduction into lung cancer, especially under conditions that might be encountered in clinical use. As a first step in addressing this important issue, the study presented here examined the ability of a recombinant retrovirus to add a selectable marker gene to the A549 non-small cell lung cancer (NSCLC) cell line under a variety of conditions. Examination of viral exposure times ranging from 30 sec to 4 hr revealed that the number of infected cells increased with every increment in time. By increasing the multiplicity of infection to 1.0 and including a polycation, Polybrene, as an infection facilitator, 0.8% of the NSCLC cells were infected with only a 30-sec viral exposure. Nebulization, a potentially attractive route of administration for pulmonary malignancies, had no significant effect on viral titer, proviral structure, or proviral transcripts. A single lyophilization did reduce viral titer by 58 +/- 6%, but did not affect the proviral structure or transcripts produced by the surviving viruses. These results suggest that recombinant retroviruses have the potential to add new genes to malignancies accessible by the airways under conditions likely required for clinical use.
authors.affiliation: Department of Medicine, UAB School of Medicine 35294.
authors.forename: M D
authors.initials: MD
authors.lastname: Rousculp
authors.forename: K T
authors.initials: KT
authors.lastname: Goldsmith
authors.forename: R I
authors.initials: RI
authors.lastname: Garver
mesh_terms: D016475:3T3 Cells; D000818:Animals; D002289:Carcinoma, Non-Small-Cell Lung / Q000235:genetics / Q000628:therapy*; D005069:Evaluation Studies as Topic; D005612:Freeze Drying; D005819:Genetic Markers; D015316:Genetic Therapy / Q000379:methods; D006801:Humans; D008175:Lung Neoplasms / Q000235:genetics / Q000628:therapy*; D051379:Mice; D009330:Nebulizers and Vaporizers; D011533:Proviruses / Q000235:genetics; D012190:Retroviridae / Q000235:genetics* / Q000502:physiology; D014161:Transduction, Genetic; D014407:Tumor Cells, Cultured; D014779:Virus Replication
chemical_list: D005819:Genetic Markers